Ecolab (ECL)

Ecolab may have a lofty valuation, but it is one of the steadiest businesses on the market.

Ecolab shares are down despite strong sales growth and reaffirmed guidance, as Q2 EPS narrowly missed estimates by $0.01.

Risk appetite took a breather Tuesday, with major U.S. stock indices retreating modestly from record highs as investors braced for a pivotal stretch of earnings and macro events.

Merit Medical appoints Medtronic veteran Martha Aronson as CEO, projecting strong Q2 revenue above estimates.

Exploring ECOLAB INC's Technical Signals and Breakout Potential: Based on good technical signals, ECOLAB INC is potentially setting up for a breakout.

Ecolab Inc. (NYSE:ECL) reported Q1 sales of $3.69 billion, down 2% Y/Y and missing consensus estimate of $3.70 billion. Organic sales grew 3% Y/Y.

Wall Street modestly up as investors await economic data and corporate earnings. Bond market continues rally, gold and oil prices fall.Wall Street rises modestly, bond market continues rally, gold and oil prices fall as investors await economic data and corporate earnings.